BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 3, 2007
View Archived Issues
HDL mimetic CSL-111 shown to reduce atherosclerotic burden in the ERASE trial
Read More
Valortim demonstrates therapeutic effect in new primate model of anthrax
Read More
Plant-derived vaccine adjuvant shows enhanced immune response against hepatitis B in mice
Read More
Avanir provides business update
Read More
Phase II study of incyclinide in acne studies 40 mg dose
Read More
PRX-00023 studied in new phase IIb trial for major depressive disorder
Read More
FDA requires additional phase III study for cintredekin besudotox
Read More
Phase I/II data for Baxter's adjuvant-free pandemic H5N1 influenza vaccine
Read More
Hollis-Eden files IND to begin clinical testing of HE-3286 for metabolic disorders
Read More
European orphan drug status for Elafin
Read More
Udenafil demonstrates efficacy in erectile dysfunction phase IIb study
Read More
Structure and biological evaluation of CKD-501 presented at the ACS meeting
Read More
Novel glucocorticoid receptor modulator profiled at Merck
Read More
Provenge recommended for approval for prostate cancer
Read More
New data presented for bifeprunox
Read More
CanBas and Takeda collaborate in cancer
Read More
Aska licenses rights to JCR's recombinant FSH
Read More
PC-190708: a novel DNA gyrase B inhibitor identified at Prolysis
Read More
New agents for treating extrapyramidal disorders disclosed in recent Kissei patents
Read More
Recent patents report novel therapeutic agents for metabolic disorders
Read More
Recent Pfizer patent discloses new treatments for attention deficit hyperactivity disorder
Read More
Ceprotin approved for severe congenital protein C deficiency
Read More
Novartis suspends U.S. sales of Zelnorm
Read More
Janumet receives FDA approval
Read More
Lapatinib filed for approval in Japan for advanced breast cancer
Read More
Abbott seeks U.S. and E.U. approval of Humira for chronic plaque psoriasis
Read More
Twinrix approved for new accelerated dosing schedule
Read More
Exjade filed in Japan
Read More